openPR Logo

Press Releases from Agendia BV (2 total)

direct/ Agendia B.V. (NL) - Agendia announces a distribution agreement with Teva …

First MammaPrint® distribution agreement for Latin-America Amsterdam, The Netherlands, November 15, 2006 Agendia B.V. (Amsterdam, The Netherlands) and Teva & Tuteur (Buenos Aires, Argentina) a leading Argentinean Pharmaceutical and Diagnostic company have signed a distribution agreement that provides Teva & Tuteur with the exclusive rights for MammaPrint® in Argentina and Paraguay. In 2002 a 70-gene tumor expression profile was established as a powerful predictor of disease outcome in breast cancer

direct/ Agendia´s MammaPrint(R) shows significant agreement with other multi-ge …

Publication in New England Journal of Medicine shows equivalence of different molecular signatures for breast cancer -- Amsterdam, The Netherlands 21.08.2006 In a publication in the August 10 2006 issue of the prestigious New England Journal of Medicine, Agendia´s MammaPrint® 70 gene breast cancer prognosis test and three other multi gene tests are shown to be superior over conventional assessment of risk of future metastatic disease. This reinforces the reliability of